Catechin prevents endothelial dysfunction in the prediabetic stage of OLETF rats by reducing vascular NADPH oxidase activity and expression

Atherosclerosis

Volumn 206, Issue 1, 2009, Pages 47-53

  Ihm, Sang Hyun ^a   Lee, Jung Ok ^b   Kim, Su Jin ^a   Seung, Ki Bae ^a   Schini Kerth, Valérie B ^c   Chang, Kyuk ^a   Oak, Min Ho ^b,c  

^a The Catholic University of Korea   (South Korea)

^b Research and Development Center   (South Korea)

^c CNRS   (France)

Author keywords

Catechin; Diabetes; Endothelial dysfunction; NADPH oxidase; Oxidative stress

Indexed keywords

CATECHIN; INSULIN; LUCIGENIN; PROTEIN P22; PROTEIN P47; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; EX VIVO STUDY; GLUCOSE TOLERANCE TEST; IMMUNOHISTOCHEMISTRY; IMPAIRED GLUCOSE TOLERANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TREATMENT DURATION; VASCULAR RING;

ANIMALS; AORTA, THORACIC; BLOOD GLUCOSE; BLOOD PRESSURE; CATECHIN; DIABETES MELLITUS, TYPE 2; INSULIN; MALE; NADPH OXIDASE; OXIDATIVE STRESS; PREDIABETIC STATE; RATS; RATS, INBRED OLETF;

EID: 69249235768     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.01.036     Document Type: Article

References (24)

1. Hudson B.I., Wendt T., Bucciarelli L.G., et al. Diabetic vascular disease: it's all the RAGE. Antioxid Redox Signal 7 (2005) 1588-1600
2. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular disease: the role of oxidant stress. Circ Res 87 (2000) 840-844
3. Mombouli J.V., and Vanhoutte P.M. Endothelial dysfunction: from physiology to therapy. J Mol Cell Cardiol 31 (1999) 61-74
4. Rajagopalan S., Kurz S., Münzel T., et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97 (1996) 1916-1923
5. Miller Jr. F.J., Gutterman D.D., Rios C.D., Heistad D.D., and Davidson B.L. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 82 (1998) 1298-1305
6. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes 40 (1991) 405-412
7. Kim Y.K., Lee M.S., Son S.M., et al. Vascular NADH oxidase is involved in impaired endothelium-dependent vasodilation in OLETF rats, a model of type 2 diabetes. Diabetes 51 (2002) 522-527
8. Hirano R., Momiyama Y., Takahashi R., et al. Comparison of green tea intake in Japanese patients with and without angiographic coronary artery disease. Am J Cardiol 90 (2002) 1150-1153
9. Mukamal K.J., Maclure M., Muller J.E., Sherwood J.B., and Mittleman M.A. Tea consumption and mortality after acute myocardial infarction. Circulation 105 (2002) 2476-2481
10. Miura Y., Chiba T., Tomita I., et al. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr 131 (2001) 27-32
11. Tijburg L.B., Wiseman S.A., Meijer G.W., and Weststrate J.A. Effects of green tea, black tea and dietary lipophilic antioxidants on LDL oxidizability and atherosclerosis in hypercholesterolaemic rabbits. Atherosclerosis 135 (1997) 37-47
12. El Bedoui J., Oak M.H., Anglard P., and Schini-Kerth V.B. Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression. Cardiovasc Res 67 (2005) 317-325
13. Miller Jr. F.J., Gutterman D.D., Rios C.D., Heistad D.D., and Davidson B.L. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 85 (1998) 1298-1305
14. Tarpey M.M., Wink D.A., and Grisham M.B. Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. Am J Physiol Regul Integr Comp Physiol 286 (2004) R431-434
15. Cai H., Griendling K.K., and Harrison D.G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 24 (2003) 471-478
16. Lassègue B., and Clempus R.E. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285 (2003) R277-297
17. Hink U., Li H., Mollnau H., et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res 88 (2001) E14-22
18. Chu K.Y., and Leung P.S. Angiotensin II Type 1 receptor antagonism mediates uncoupling protein 2-driven oxidative stress and ameliorates pancreatic islet beta-cell function in young Type 2 diabetic mice. Antioxid Redox Signal 9 (2007) 869-878
19. Stangl V., Dreger H., Stangl K., and Lorenz M. Molecular targets of tea polyphenols in the cardiovascular system. Cardiovasc Res 73 (2007) 348-358
20. Kim W., Jeong M.H., Cho S.H., et al. Effect of green tea consumption on endothelial function and circulating endothelial progenitor cells in chronic smokers. Circ J 70 (2006) 1052-1057
21. Nagao T., Hase T., and Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity 15 (2007) 1473-1483
22. Wu L.Y., Juan C.C., Ho L.T., Hsu Y.P., and Hwang L.S. Effect of green tea supplementation on insulin sensitivity in Sprague-Dawley rats. J Agric Food Chem 52 (2004) 643-648
23. Sarr M., Chataigneau M., Martins S., et al. Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase. Cardiovasc Res 71 (2006) 794-802
24. Negishi H., Xu J.W., Ikeda K., Njelekela M., Nara Y., and Yamori Y. Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. J Nutr 134 (2004) 38-42